Selected research
Industry Research
Pemirolast Industry Research Report 2026
Market perspective
The global Pemirolast market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pemirolast is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pemirolast is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pemirolast is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pemirolast include SAMYANG CHEMICAL, SanTen, Vegesna Laboratories, Toronto Research Chemicals, LGM Pharma, Jiaxing Epochem Pharmtech, FEIMA YAOYE, Clearsynth and ChemScence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pemirolast market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pemirolast Market by Company
SAMYANG CHEMICAL
SanTen
Vegesna Laboratories
Toronto Research Chemicals
LGM Pharma
Jiaxing Epochem Pharmtech
FEIMA YAOYE
Clearsynth
ChemScence
AESCU PHARMA
Pemirolast Segment by Type
Drop
Tablet
Other
Pemirolast Segment by Application
Eye Disease
Asthma
Other
Pemirolast Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemirolast market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pemirolast and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemirolast.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pemirolast manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pemirolast by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pemirolast in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drop
- Tablet
- Other
Applications
- Eye Disease
- Asthma
- Other
Companies covered
- SAMYANG CHEMICAL
- SanTen
- Vegesna Laboratories
- Toronto Research Chemicals
- LGM Pharma
- Jiaxing Epochem Pharmtech
- FEIMA YAOYE
- Clearsynth
- ChemScence
- AESCU PHARMA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pemirolast Market Size (2021-2032)
- 2.2.2 Global Pemirolast Sales (2021-2032)
- 2.2.3 Global Pemirolast Market Average Price (2021-2032)
- 2.3 Pemirolast by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drop
- 2.3.3 Tablet
- 2.3.4 Other
- 2.4 Pemirolast by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Eye Disease
- 2.4.3 Asthma
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pemirolast Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pemirolast Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pemirolast Revenue of Manufacturers (2021-2026)
- 3.4 Global Pemirolast Average Price by Manufacturers (2021-2026)
- 3.5 Global Pemirolast Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pemirolast, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pemirolast, Product Type & Application
- 3.8 Global Manufacturers of Pemirolast, Established Date
- 3.9 Global Pemirolast Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SAMYANG CHEMICAL
- 4.1.1 SAMYANG CHEMICAL Company Information
- 4.1.2 SAMYANG CHEMICAL Business Overview
- 4.1.3 SAMYANG CHEMICAL Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SAMYANG CHEMICAL Pemirolast Product Portfolio
- 4.1.5 SAMYANG CHEMICAL Recent Developments
- 4.2 SanTen
- 4.2.1 SanTen Company Information
- 4.2.2 SanTen Business Overview
- 4.2.3 SanTen Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SanTen Pemirolast Product Portfolio
- 4.2.5 SanTen Recent Developments
- 4.3 Vegesna Laboratories
- 4.3.1 Vegesna Laboratories Company Information
- 4.3.2 Vegesna Laboratories Business Overview
- 4.3.3 Vegesna Laboratories Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vegesna Laboratories Pemirolast Product Portfolio
- 4.3.5 Vegesna Laboratories Recent Developments
- 4.4 Toronto Research Chemicals
- 4.4.1 Toronto Research Chemicals Company Information
- 4.4.2 Toronto Research Chemicals Business Overview
- 4.4.3 Toronto Research Chemicals Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Toronto Research Chemicals Pemirolast Product Portfolio
- 4.4.5 Toronto Research Chemicals Recent Developments
- 4.5 LGM Pharma
- 4.5.1 LGM Pharma Company Information
- 4.5.2 LGM Pharma Business Overview
- 4.5.3 LGM Pharma Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LGM Pharma Pemirolast Product Portfolio
- 4.5.5 LGM Pharma Recent Developments
- 4.6 Jiaxing Epochem Pharmtech
- 4.6.1 Jiaxing Epochem Pharmtech Company Information
- 4.6.2 Jiaxing Epochem Pharmtech Business Overview
- 4.6.3 Jiaxing Epochem Pharmtech Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiaxing Epochem Pharmtech Pemirolast Product Portfolio
- 4.6.5 Jiaxing Epochem Pharmtech Recent Developments
- 4.7 FEIMA YAOYE
- 4.7.1 FEIMA YAOYE Company Information
- 4.7.2 FEIMA YAOYE Business Overview
- 4.7.3 FEIMA YAOYE Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 FEIMA YAOYE Pemirolast Product Portfolio
- 4.7.5 FEIMA YAOYE Recent Developments
- 4.8 Clearsynth
- 4.8.1 Clearsynth Company Information
- 4.8.2 Clearsynth Business Overview
- 4.8.3 Clearsynth Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Clearsynth Pemirolast Product Portfolio
- 4.8.5 Clearsynth Recent Developments
- 4.9 ChemScence
- 4.9.1 ChemScence Company Information
- 4.9.2 ChemScence Business Overview
- 4.9.3 ChemScence Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ChemScence Pemirolast Product Portfolio
- 4.9.5 ChemScence Recent Developments
- 4.10 AESCU PHARMA
- 4.10.1 AESCU PHARMA Company Information
- 4.10.2 AESCU PHARMA Business Overview
- 4.10.3 AESCU PHARMA Pemirolast Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AESCU PHARMA Pemirolast Product Portfolio
- 4.10.5 AESCU PHARMA Recent Developments
5 Global Pemirolast Market Scenario by Region
- 5.1 Global Pemirolast Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pemirolast Sales by Region: 2021-2032
- 5.2.1 Global Pemirolast Sales by Region: 2021-2026
- 5.2.2 Global Pemirolast Sales by Region: 2027-2032
- 5.3 Global Pemirolast Revenue by Region: 2021-2032
- 5.3.1 Global Pemirolast Revenue by Region: 2021-2026
- 5.3.2 Global Pemirolast Revenue by Region: 2027-2032
- 5.4 North America Pemirolast Market Facts & Figures by Country
- 5.4.1 North America Pemirolast Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pemirolast Sales by Country (2021-2032)
- 5.4.3 North America Pemirolast Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pemirolast Market Facts & Figures by Country
- 5.5.1 Europe Pemirolast Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pemirolast Sales by Country (2021-2032)
- 5.5.3 Europe Pemirolast Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Pemirolast Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pemirolast Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pemirolast Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pemirolast Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pemirolast Market Facts & Figures by Country
- 5.7.1 South America Pemirolast Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pemirolast Sales by Country (2021-2032)
- 5.7.3 South America Pemirolast Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pemirolast Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pemirolast Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pemirolast Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pemirolast Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pemirolast Sales by Type (2021-2032)
- 6.1.1 Global Pemirolast Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pemirolast Sales Market Share by Type (2021-2032)
- 6.2 Global Pemirolast Revenue by Type (2021-2032)
- 6.2.1 Global Pemirolast Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pemirolast Revenue Market Share by Type (2021-2032)
- 6.3 Global Pemirolast Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pemirolast Sales by Application (2021-2032)
- 7.1.1 Global Pemirolast Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pemirolast Sales Market Share by Application (2021-2032)
- 7.2 Global Pemirolast Revenue by Application (2021-2032)
- 7.2.1 Global Pemirolast Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pemirolast Revenue Market Share by Application (2021-2032)
- 7.3 Global Pemirolast Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pemirolast Value Chain Analysis
- 8.1.1 Pemirolast Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pemirolast Production Mode & Process
- 8.2 Pemirolast Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pemirolast Distributors
- 8.2.3 Pemirolast Customers
9 Global Pemirolast Analyzing Market Dynamics
- 9.1 Pemirolast Industry Trends
- 9.2 Pemirolast Industry Drivers
- 9.3 Pemirolast Industry Opportunities and Challenges
- 9.4 Pemirolast Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst